Hybrid nanocomposites for imaging-guided synergistic theranostics

Lin Deng, Zhirong Liu, Linlin Li

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

18 Citations (Scopus)

Abstract

Imaging-guided stimuli-responsive drug delivery systems have emerged as a functional platform in cancer theranostics. The encapsulation of various functional nanoparticles into one nanocarrier has been evaluated over the past 10 years to develop effective drug delivery and cell/tissue imaging for cancer diagnosis and therapy. Among them, the combination of photothermal therapy (PTT), chemotherapy, and diagnostic imaging is the most popular way due to their bright, foreseeable future. The novel nanomedicine platform is a promising method to enhance therapeutic efficiency and reduce the side effects. In this chapter, PTT and the corresponding nanomaterials are introduced. The conventional and novel imaging technologies are then reviewed, including the characteristics of nanomaterials as contrast agents. The imaging-guided PTT and chemotherapy are summarized, focusing on three typical materials, gold nanoparticles, carbon nanomaterials and polymeric nanomaterials. In conclusion, imaging-guided synergistic photothermal and chemotherapy, which is becoming one of the mainstream solution for cancer theranostics in the future, is reviewed. It will certainly help us to enter a new stage of personalized cancer treatment.

Original languageEnglish
Title of host publicationNanomaterials for Drug Delivery and Therapy
PublisherElsevier
Pages117-147
Number of pages31
ISBN (Electronic)9780128165058
DOIs
Publication statusPublished - 1 Jan 2019
Externally publishedYes

Keywords

  • Cancer diagnosis
  • Cancer therapy
  • Chemotherapy
  • Multimodal imaging
  • Photothermal therapy
  • Theranostics

Fingerprint

Dive into the research topics of 'Hybrid nanocomposites for imaging-guided synergistic theranostics'. Together they form a unique fingerprint.

Cite this